Astera Labs, Inc.
ALAB
$287.48
$43.2217.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.96% | 17.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.96% | 17.35% | |||
| Cost of Revenue | 10.76% | 20.72% | |||
| Gross Profit | 15.00% | 16.30% | |||
| SG&A Expenses | 9.03% | 5.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.07% | 16.24% | |||
| Operating Income | -7.65% | 20.85% | |||
| Income Before Tax | -6.97% | 18.03% | |||
| Income Tax Expenses | -120.32% | 239.92% | |||
| Earnings from Continuing Operations | 78.54% | -50.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 78.54% | -50.63% | |||
| EBIT | -7.65% | 20.85% | |||
| EBITDA | -6.10% | 22.74% | |||
| EPS Basic | 77.24% | -51.23% | |||
| Normalized Basic EPS | -7.63% | 16.59% | |||
| EPS Diluted | 75.37% | -49.82% | |||
| Normalized Diluted EPS | -6.94% | 17.68% | |||
| Average Basic Shares Outstanding | 0.72% | 1.24% | |||
| Average Diluted Shares Outstanding | -0.01% | 0.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||